EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Scotts Miracle-Gro (SMG)

Consumer Discretionary

Antya Investments

A contemporary gordian knot - after a complete failure at anticipating and forecasting demand trends and overseeing a decline of 71% in the stock price during FY22, management now predicts $1bn in combined FCF during FY23 & FY24. FCF has swiftly become important with Debt/EBITDA increasing from 2.96x (Sep 2019) to 6.03x (Sep 22) and set to deteriorate further in 1H23. Neeraj Monga does not buy into the turnaround story and believes the current rally in SMG’s stock price is the perfect time to bail out. Trading at a premium to its long-term pre-Covid mean valuation, Neeraj argues that after considering all plausible optimistic outcomes, the stock is at best worth $44/share.

Edition: 153

- 03 February, 2023


Scotts Miracle-Gro (SMG)

Consumer Discretionary

Two Rivers Analytics

This new short idea was generated from Eric Fernandez's Earnings Quality Model - the core lawn care business is caught between rising fertiliser prices and declining demand after the Covid “fix-up-your-home” wave began to dissipate. At the same time, SMG’s cannabis growth strategy has fallen apart. The cannabis industry faces overcapacity that has decimated its Hawthorne segment, leading to a 65% decline in sales last quarter. Leverage remains alarmingly high (proforma leverage is 6.8x next year’s EBITDA) and while management has embarked on a restructuring plan to reduce expenses and inventory, and reclaim margins, Eric believes forecasts are overly optimistic.

Edition: 143

- 02 September, 2022


Value stocks for 2022: Uber (UBER), Bank of America (BAC), Scotts Miracle-Gro (SMG)

Boyar Research

Jonathan Boyar recently spoke to Barron’s about Boyar's Forgotten Forty portfolio which has produced an average annual gain of 11.5% over the last decade - all the companies highlighted are businesses which they believe are most likely to outperform the leading indices in the year ahead due to a catalyst on the horizon. Stocks discussed include:

UBER - Profitability in Mobility business is underestimated. It also holds valuable equity stakes in other ride-hailing businesses worth ~$10bn. TP $79 (100%+ upside).
BAC - The most interest rate sensitive of the major US banks; lots of room for NII to rise. TP $61 (30% upside).
SMG - Cannabis business (which has grown 100% in the last 2 years) is in the price for free. TP $242 (~75% upside).

Edition: 129

- 18 February, 2022